Invesco Past Earnings Performance
Past criteria checks 0/6
Invesco's earnings have been declining at an average annual rate of -22.6%, while the Capital Markets industry saw earnings growing at 7.9% annually. Revenues have been declining at an average rate of 1.7% per year.
Key information
-22.6%
Earnings growth rate
-23.0%
EPS growth rate
| Capital Markets Industry Growth | 10.3% |
| Revenue growth rate | -1.7% |
| Return on equity | -1.0% |
| Net Margin | -7.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Invesco: An Asset Manager With Upside
Oct 28Invesco's (NYSE:IVZ) Dividend Will Be $0.205
Oct 25
Invesco Ltd.'s (NYSE:IVZ) Price Is Right But Growth Is Lacking
Oct 07Invesco's (NYSE:IVZ) Dividend Will Be $0.205
Aug 14Invesco: Not Concerned About The Unwind
Aug 08Invesco (NYSE:IVZ) Has Announced A Dividend Of $0.205
Jul 26Invesco (NYSE:IVZ) Has Announced That It Will Be Increasing Its Dividend To $0.205
May 07Revenues Working Against Invesco Ltd.'s (NYSE:IVZ) Share Price
Mar 24Invesco: No Pricing Power In An Inflationary Environment
Feb 21Invesco Ltd.'s (NYSE:IVZ) Shares Bounce 27% But Its Business Still Trails The Market
Dec 18Invesco: Industry Headwinds And Threats To Its Business Model
Dec 07Invesco: Active AUM Outflows Remains A Concern
Oct 26Invesco: Headwinds From Passive Shift And Risks Of Shift To Deposits
Aug 27Invesco: Maintaining Strong Fundamentals After Its Rally, Still A 'Buy'
Jun 19Invesco names Andrew Schlossberg to success Marty Flanagan as president, CEO
Feb 08Invesco: Shares Rally Above Resistance, Valuation Intriguing Ahead Of Earnings
Jan 20Invesco December AUM slips 2% on disappointing market returns
Jan 11Invesco AUM ascends about 6% in November on positive market returns
Dec 12Invesco - Revisiting The Upside In A Market Turnaround - It's Gone Too Far
Nov 16Invesco AUM gains 2.8% in October on market returns
Nov 09Revenue & Expenses Breakdown
How Invesco makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 5,887 | -414 | 562 | 0 |
| 30 Jun 24 | 5,814 | -337 | 577 | 0 |
| 31 Mar 24 | 5,774 | -337 | 586 | 0 |
| 31 Dec 23 | 5,716 | -334 | 574 | 0 |
| 30 Sep 23 | 5,746 | 596 | 291 | 0 |
| 30 Jun 23 | 5,750 | 642 | 607 | 0 |
| 31 Mar 23 | 5,838 | 631 | 586 | 0 |
| 31 Dec 22 | 6,049 | 684 | 565 | 0 |
| 30 Sep 22 | 6,369 | 923 | 520 | 0 |
| 30 Jun 22 | 6,673 | 1,076 | 560 | 0 |
| 31 Mar 22 | 6,864 | 1,323 | 534 | 0 |
| 31 Dec 21 | 6,895 | 1,393 | 523 | 0 |
| 30 Sep 21 | 6,761 | 1,177 | 873 | 0 |
| 30 Jun 21 | 6,509 | 1,039 | 462 | 0 |
| 31 Mar 21 | 6,206 | 711 | 538 | 0 |
| 31 Dec 20 | 6,146 | 525 | 564 | 0 |
| 30 Sep 20 | 6,258 | 494 | 610 | 0 |
| 30 Jun 20 | 6,481 | 469 | 643 | 0 |
| 31 Mar 20 | 6,502 | 469 | 567 | 0 |
| 31 Dec 19 | 6,117 | 565 | 540 | 0 |
| 30 Sep 19 | 5,631 | 499 | 538 | 0 |
| 30 Jun 19 | 5,252 | 602 | 495 | 0 |
| 31 Mar 19 | 5,173 | 807 | 486 | 0 |
| 31 Dec 18 | 5,314 | 883 | 459 | 0 |
| 30 Sep 18 | 5,434 | 1,177 | 440 | 0 |
| 30 Jun 18 | 5,430 | 1,175 | 457 | 0 |
| 31 Mar 18 | 5,324 | 1,169 | 446 | 0 |
| 31 Dec 17 | 5,160 | 1,127 | 429 | 0 |
| 30 Sep 17 | 4,979 | 946 | 501 | 0 |
| 30 Jun 17 | 4,843 | 919 | 495 | 0 |
| 31 Mar 17 | 4,778 | 905 | 493 | 0 |
| 31 Dec 16 | 4,734 | 854 | 409 | 0 |
| 30 Sep 16 | 4,779 | 849 | 481 | 0 |
| 30 Jun 16 | 4,851 | 851 | 487 | 0 |
| 31 Mar 16 | 4,980 | 876 | 499 | 0 |
| 31 Dec 15 | 5,123 | 968 | 522 | 0 |
| 30 Sep 15 | 5,160 | 1,010 | 550 | 0 |
| 30 Jun 15 | 5,197 | 1,016 | 580 | 0 |
| 31 Mar 15 | 5,169 | 1,032 | 567 | 0 |
| 31 Dec 14 | 5,147 | 992 | 595 | 0 |
| 30 Sep 14 | 5,096 | 921 | 571 | 0 |
| 30 Jun 14 | 4,956 | 901 | 530 | 0 |
| 31 Mar 14 | 4,802 | 842 | 526 | 0 |
| 31 Dec 13 | 4,645 | 844 | 473 | 0 |
Quality Earnings: IVZ is currently unprofitable.
Growing Profit Margin: IVZ is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IVZ is unprofitable, and losses have increased over the past 5 years at a rate of 22.6% per year.
Accelerating Growth: Unable to compare IVZ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IVZ is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (13%).
Return on Equity
High ROE: IVZ has a negative Return on Equity (-0.96%), as it is currently unprofitable.